FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.34B
1-Year Est. Return
92.56%
1 Year Est. Return
+92.56%
AUM
$3.34B
AUM Growth
+$837M
(+33%)
Holding
53
Top Buys
| 1 | +$32.1M | |
| 2 | +$18.5M | |
| 3 | +$15.3M | |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$13.1M |
| 5 |
Assembly Biosciences
ASMB
|
+$11.7M |
Top Sells
| 1 | +$21.1M | |
| 2 | +$20M | |
| 3 | +$14.6M | |
| 4 |
Disc Medicine
IRON
|
+$14.3M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLVX
51
DELISTED
HilleVax
HLVX
| – | – |
-10,617,062
|
|
||
52
Oric Pharmaceuticals
ORIC
$1.09B
| – | – |
-1,065,334
|
|
||
|
ORKA
53
Oruka Therapeutics
ORKA
$1.34B
| – | – |
-583,327
|
|